Edward D Frohlich

Review: Promise of prevention and reversal of target organ involvement in hypertension
J Renin Angiotensin Aldosterone Syst 2001 2: S4-S9. [PDF] [References]  

Thomas M Coffman, Laurent P Audoly, and Michael I Oliverio

Review: Gene targeting studies of angiotensin II type 1 (AT1) receptors
J Renin Angiotensin Aldosterone Syst 2001 2: S10-S15. [PDF] [References]  

László Hunyady, Zsuzsanna Gáborik, Georges Vauquelin, and Kevin J Catt

Review: Structural requirements for signalling and regulation of AT1-receptors
J Renin Angiotensin Aldosterone Syst 2001 2: S16-S23. [PDF] [References]  

Georges Vauquelin, Frederik LP Fierens, Ilse Verheijen, and Patrick ML Vanderheyden

Distinctions between non-peptide angiotensin II AT1-receptor antagonists
J Renin Angiotensin Aldosterone Syst 2001 2: S24-S31. [Abstract] [PDF] [References]  

Georges Vauquelin, Frederik LP Fierens, Zsuzsanna Gáborik, Tam Le Minh, Jean-Paul De Backer, László Hunyady, and Patrick ML Vanderheyden

Role of basic amino acids of the human angiotensin type 1 receptor in the binding of the non-peptide antagonist candesartan
J Renin Angiotensin Aldosterone Syst 2001 2: S32-S36. [Abstract] [PDF] [References]  

Hoa Ytterberg and Lars Edvinsson

Characterisation of angiotensin II receptors in isolated human subcutaneous resistance arteries
J Renin Angiotensin Aldosterone Syst 2001 2: S37-S41. [Abstract] [PDF] [References]  

Hoa Ytterberg and Lars Edvinsson

Evidence for a cyclic AMP-dependent pathway in angiotensin AT1-receptor activation of human omental arteries
J Renin Angiotensin Aldosterone Syst 2001 2: S42-S47. [Abstract] [PDF] [References]  

Trinity J Bivalacqua, Hunter C Champion, Albert L Hyman, Dennis B McNamara, and Philip J Kadowitz

Analysis of responses to angiotensin II in the mouse
J Renin Angiotensin Aldosterone Syst 2001 2: S48-S53. [Abstract] [PDF] [References]  

Marc P Maillard, Catherine Centeno, Åsa Frostell-Karlsson, Hans R Brunner, and Michel Burnier

Does protein binding modulate the effect of angiotensin II receptor antagonists?
J Renin Angiotensin Aldosterone Syst 2001 2: S54-S58. [Abstract] [PDF] [References]  

Ming-Sheng Zhou, Ahmed Adam, and Leopoldo Raij

Review: Interaction among angiotensin II, nitric oxide and oxidative stress
J Renin Angiotensin Aldosterone Syst 2001 2: S59-S63. [PDF] [References]  

Lodewijk J Wagenaar, Hendrik Buikema, Yigal M Pinto, and Wiek H van Gilst

Improvement of endothelial dysfunction in experimental heart failure by chronic RAAS-blockade: ACE-inhibition or AT1-receptor blockade?
J Renin Angiotensin Aldosterone Syst 2001 2: S64-S69. [Abstract] [PDF] [References]  

Jawahar L Mehta and Dayuan Li

Facilitative interaction between angiotensin II and oxidised LDL in cultured human coronary artery endothelial cells
J Renin Angiotensin Aldosterone Syst 2001 2: S70-S76. [Abstract] [PDF] [References]  

Vasilios Papademetriou, Philippe Mammillot, Robert Redman, Aldo Notargiacomo, Puneet Narayan, and Raj Lakshman

Prevention of atherosclerosis by specific AT1-receptor blockade with candesartan cilexetil
J Renin Angiotensin Aldosterone Syst 2001 2: S77-S80. [Abstract] [PDF] [References]  

Prakash Koshy, Amanda Self, Philip J Kadowitz, Vivian A Fonseca, and Dennis B McNamara

Effects of low-dose candesartan on the rate of re-endothelialisation following vascular wound healing
J Renin Angiotensin Aldosterone Syst 2001 2: S81-S83. [Abstract] [PDF] [References]  

Daniel Casellas, Abderraouf Herizi, Annie Artuso, Albert Mimran, and Bernard Jover

Candesartan prevents L-NAME-induced cardio-renal injury in spontaneously hypertensive rats beyond hypotensive effects
J Renin Angiotensin Aldosterone Syst 2001 2: S84-S90. [Abstract] [PDF] [References]  

Karin Skov, Susie Mogensen, and Michael J Mulvany

Persistent effect of treatment with candesartan cilexetil on blood pressure in spontaneously hypertensive rats
J Renin Angiotensin Aldosterone Syst 2001 2: S91-S94. [Abstract] [PDF] [References]  

Andrew M Allen, Michelle E Giles, JooHyung Lee, Brian J Oldfield, Frederick AO Mendelsohn, and Michael J McKinley

Review: AT1-receptors in the central nervous system
J Renin Angiotensin Aldosterone Syst 2001 2: S95-S101. [PDF] [References]  

Juan M Saavedra, Takeshi Ito, and Yasuaki Nishimura

Review: The role of angiotensin II AT1-receptors in the regulation of the cerebral blood flow and brain ischaemia
J Renin Angiotensin Aldosterone Syst 2001 2: S102-S109. [PDF] [References]  

Gerald F DiBona

Review: Role of angiotensin in central regulation of sympathetic activity: effect of dietary sodium chloride
J Renin Angiotensin Aldosterone Syst 2001 2: S110-S113. [PDF] [References]  

Arya M Sharma and Stefan Engeli

The renin-angiotensin system in obesity hypertension
J Renin Angiotensin Aldosterone Syst 2001 2: S114-S119. [PDF] [References]  

Andrew M Allen

Blockade of angiotensin AT1-receptors in the rostral ventrolateral medulla of spontaneously hypertensive rats reduces blood pressure and sympathetic nerve discharge
J Renin Angiotensin Aldosterone Syst 2001 2: S120-S124. [Abstract] [PDF] [References]  

Donna H Wang and Yan Huang

Development of salt-sensitive hypertension in a sensory denervated model: the underlying mechanisms
J Renin Angiotensin Aldosterone Syst 2001 2: S125-S129. [Abstract] [PDF] [References]  

Ines Armando, Andrea Carranza, Yasuaki Nishimura, Marta Barontini, Takeshi Ito, and Juan M Saavedra

Candesartan decreases the sympatho-adrenal and hormonal response to isolation stress
J Renin Angiotensin Aldosterone Syst 2001 2: S130-S135. [Abstract] [PDF] [References]  

Rainer Schulz and Gerd Heusch

Review: AT 1-receptor blockade in experimental myocardial ischaemia/reperfusion
J Renin Angiotensin Aldosterone Syst 2001 2: S136-S140. [PDF] [References]  

Lindsay Brown, Andrew Fenning, Annie Shek, and Darryl Burstow

Reversal of cardiovascular remodelling with candesartan
J Renin Angiotensin Aldosterone Syst 2001 2: S141-S147. [Abstract] [PDF] [References]  

Emad Abro, Cory D Griffiths, Trefor O Morgan, and Lea MD Delbridge

Regression of cardiac hypertrophy in the SHR by combined renin-angiotensin system blockade and dietary sodium restriction
J Renin Angiotensin Aldosterone Syst 2001 2: S148-S153. [Abstract] [PDF] [References]  

Djamel Lebeche, Zhao Bin Kang, and Roger Hajjar

Candesartan abrogates G protein-coupled receptors agonist-induced MAPK activation and cardiac myocyte hypertrophy
J Renin Angiotensin Aldosterone Syst 2001 2: S154-S161. [Abstract] [PDF] [References]  

Bodh I Jugdutt, Yi Xu, Mohammed Balghith, and Vijayan Menon

Cardioprotective effects of angiotensin II type 1 receptor blockade with candesartan after reperfused myocardial infarction: role of angiotensin II type 2 receptor
J Renin Angiotensin Aldosterone Syst 2001 2: S162-S166. [Abstract] [PDF] [References]  

William J Arendshorst

Review: Lessons on renal function from transgenic mice lacking different angiotensin II receptors
J Renin Angiotensin Aldosterone Syst 2001 2: S167-S175. [PDF] [References]  

L Gabriel Navar, Kenneth D Mitchell, Lisa M Harrison-Bernard, Hiroyuki Kobori, and Akira Nishiyama

Review: Intrarenal angiotensin II levels in normal and hypertensive states
J Renin Angiotensin Aldosterone Syst 2001 2: S176-S184. [PDF] [References]  

Norman K Hollenberg

Review: The renin-angiotensin-aldosterone system, blockade and diabetic nephropathy
J Renin Angiotensin Aldosterone Syst 2001 2: S185-S187. [PDF] [References]  

Matthew R Weir and Chiming Wei

The role of angiotensin II and TGF-beta on the progression of chronic allograft nephropathy
J Renin Angiotensin Aldosterone Syst 2001 2: S188-S190. [Abstract] [PDF] [References]  

Karen A Griffin, Maria M Picken, George Bakris, and Anil K Bidani

Relative antihypertensive and glomeruloprotective efficacies of enalapril and candesartan cilexetil in the remnant kidney model
J Renin Angiotensin Aldosterone Syst 2001 2: S191-S195. [Abstract] [PDF] [References]  

Marc S Weinberg, Adam J Weinberg, Raymond Cord, and Dion H Zappe

The effect of high-dose angiotensin II receptor blockade beyond maximal recommended doses in reducing urinary protein excretion
J Renin Angiotensin Aldosterone Syst 2001 2: S196-S198. [Abstract] [PDF] [References]  

Jürgen Schnermann, Yuning G Huang, and Josie P Briggs

Angiotensin II blockade causes acute renal failure in eNOS-deficient mice
J Renin Angiotensin Aldosterone Syst 2001 2: S199-S203. [Abstract] [PDF] [References]  

William F van Rodijnen, Ton A van Lambalgen, Marco E van Teijlingen, Geert-Jan Tangelder, and Piet M ter Wee

Comparison of the AT1-receptor blockers candesartan, irbesartan and losartan for inhibiting renal microvascular constriction
J Renin Angiotensin Aldosterone Syst 2001 2: S204-S210. [Abstract] [PDF] [References]  

Jean-Jacques Boffa, Ying Lu, Jean-Claude Dussaule, and Christos Chatziantoniou

Improvements of renal lesions and function by angiotensin and endothelin receptor antagonism in nitric oxide-deficient rats
J Renin Angiotensin Aldosterone Syst 2001 2: S211-S216. [Abstract] [PDF] [References]  

Matthew R Weir and Rebecca Y Wang

Use of angiotensin II receptor blockers alone and in combination with other drugs: a large clinical experience trial
J Renin Angiotensin Aldosterone Syst 2001 2: S217-S222. [Abstract] [PDF] [References]  

Trefor Morgan

Review: Effect of combining angiotensin receptor blockers and ACE inhibitors on cardiovascular disease
J Renin Angiotensin Aldosterone Syst 2001 2: S223-S226. [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.